Genomic activation of the EGFR and HER2-neu genes in a significant proportion of invasive epithelial ovarian cancers. - Wikidata - wikimedia - TriplyDB

Genomic activation of the EGFR and HER2-neu genes in a significant proportion of invasive epithelial ovarian cancers.

Genomic activation of the EGFR and HER2-neu genes in a significant proportion of invasive epithelial ovarian cancers.

http://www.wikidata.org/entity/Q33313648

about

Model-based analysis of HER activation in cells co-expressing EGFR, HER2 and HER3 Genomics of squamous cell lung cancer An intracellular targeted antibody detects EGFR as an independent prognostic factor in ovarian carcinomas.Vandetanib, designed to inhibit VEGFR2 and EGFR signaling, had no clinical activity as monotherapy for recurrent ovarian cancer and no detectable modulation of VEGFR2.Assessing HER2 amplification by IHC, FISH, and real-time polymerase chain reaction analysis (real-time PCR) following LCM in formalin-fixed paraffin embedded tissue from 40 women with ovarian cancer HER2 in solid tumors: more than 10 years under the microscope; where are we now?Targeting HSP90 in ovarian cancers with multiple receptor tyrosine kinase coactivation.Genetic variability in EGFR, Src and HER2 and risk of colorectal adenoma and cancer.Molecular Mechanisms of Trastuzumab Resistance in HER2 Overexpressing Breast Cancer Lack of prognostic relevance of Her-2/neu, topoisomerase IIα and EGFR in advanced ovarian carcinoma.Activating Mutations in ERBB2 and Their Impact on Diagnostics and Treatment.Synthetic genetic targeting of genome instability in cancer.Targeting the epidermal growth factor receptor in epithelial ovarian cancer: current knowledge and future challenges.EGFR(S) inhibitors in the treatment of gastro-intestinal cancers: what's new?Inhibition of Cdc42 is essential for Mig-6 suppression of cell migration induced by EGF.HER3 mRNA as a predictive biomarker in anticancer therapy.A caspase-6 and anti-HER2 antibody chimeric tumor-targeted proapoptotic molecule decreased metastasis of human osteosarcoma.Identification of the coexisting HER2 gene amplification and novel mutations in the HER2 protein-overexpressed mucinous epithelial ovarian cancer.

P2860

Q31129446-869E6297-B7D8-48E5-844D-6557F5DACEA6 Q33777454-7BB5F4A1-B47A-46DE-8258-B2F632E8BBC7 Q33960748-9C498E3B-A6EA-4129-83B4-0893473B63DF Q34147360-BBA13FB5-2F4C-4FBD-B991-6F3D9FCC1A38 Q34431788-AE671991-9685-4442-8479-1F6A225A4565 Q35211263-84881C11-E837-49CD-BFC3-2BA128024CE2 Q35390011-176A9726-05A4-42A6-9365-F6A78F23FF6F Q35627924-3C9D121C-6181-402F-9CBB-340FFA91FD70 Q35684440-40FCCAB7-BE80-442E-8C66-D6925A542603 Q36224562-AF99AB7C-7670-4288-9F2E-A7C39721B526 Q36785721-853A32D7-A230-43A7-B33A-02ECDCE2D2BE Q37226478-B8145141-1E30-48EF-B83C-BA1B5768F95B Q37485865-E8133C52-9240-4A8A-ADE6-5447ED83A954 Q37561771-77469B37-7404-4671-8502-385F8633CD05 Q37580198-B4A7C05D-A1C8-4638-B8E3-B11FF0A3CE2B Q37778843-878F0ADE-33E4-4B14-9439-DFC6D51C6429 Q39844042-26CAB284-ADD5-4E9A-9D40-C7D743022205 Q54386228-524B23B2-0576-4F8D-A130-F9F0B0EF41AB

P2860

Genomic activation of the EGFR and HER2-neu genes in a significant proportion of invasive epithelial ovarian cancers.

http://www.wikidata.org/entity/Q33313648

description

2008 nî lūn-bûn

@nan

2008 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Genomic activation of the EGFR ...... ve epithelial ovarian cancers.

@ast

Genomic activation of the EGFR ...... ve epithelial ovarian cancers.

@en

Genomic activation of the EGFR ...... ve epithelial ovarian cancers.

@nl

type

label

Genomic activation of the EGFR ...... ve epithelial ovarian cancers.

@ast

Genomic activation of the EGFR ...... ve epithelial ovarian cancers.

@en

Genomic activation of the EGFR ...... ve epithelial ovarian cancers.

@nl

prefLabel

Genomic activation of the EGFR ...... ve epithelial ovarian cancers.

@ast

Genomic activation of the EGFR ...... ve epithelial ovarian cancers.

@en

Genomic activation of the EGFR ...... ve epithelial ovarian cancers.

@nl

P1433

Q33313648-B383065B-D073-40A5-ABE1-3D9FF0586B2F

P1476

Q33313648-C663ED5E-4DC1-41F6-A769-0EA908CE78C3

P2093

Q33313648-6EBD8890-E71F-4684-905D-584448FC4CE7

Q33313648-71D5236B-FBCC-432C-8A8E-8914054FECBC

Q33313648-93F49F1D-6B4D-4C12-A668-D33BAB0D5773

Q33313648-9B75F930-2697-4359-AC52-4DE16A1E705F

Q33313648-A708CB9D-06D3-4D48-A160-2001F184FA6E

Q33313648-AF01C708-1C75-435A-AA57-83FFDCFB1DD1

Q33313648-D09A31AD-FCA5-4E85-A26C-B5BAADA62CA8

Q33313648-F6B18A80-4073-430A-8CC8-AE401AD1A526

P2860

Q33313648-095829BF-6F66-4636-B1E5-F868F1276C30

Q33313648-0A328E87-B926-449B-BC88-2F1417BBC332

Q33313648-0DE881C2-21BE-429E-B886-346551D80076

Q33313648-1FA21D2C-A0C4-4603-8F99-0E23940AAEB1

Q33313648-23A0B2A1-5B2D-4882-BDA5-75D189FF2046

Q33313648-3244DE7E-6C52-4DB0-B443-E36F61668E7B

Q33313648-38415011-5E7A-4744-BE40-6691881164B1

Q33313648-38DF9AB5-A9D3-4DFC-9A76-DFC1B09B96EB

Q33313648-39BB02AF-311B-4AEA-80AB-48F22DB5C4EC

Q33313648-5B91E775-BF0E-48AA-9178-BD996E657B17

P2888

Q33313648-D34D146B-5DF7-4E12-9F4B-F7856A95EE8B

P304

Q33313648-28300E80-4B6A-4063-8402-6C3D04AF0F60

P31

Q33313648-F3D4FB02-742D-450F-BA0D-9DF4ED7D62A1

P356

Q33313648-F7459265-F738-4A53-B044-8DF26246344D

P407

Q33313648-78CFE40A-B9EA-4FC1-9C5F-C313DDE3670E

P478

Q33313648-77434EBF-34F4-4609-BD19-DE9C127872DA

P577

Q33313648-51F3AA58-B331-422F-BED0-34B125CDA0DB

P5875

Q33313648-882863B3-7F96-4EA4-8983-C68E22EFC1D3

P6179

Q33313648-C2F9D7E0-3033-4760-BBAE-237E4FDB6DCE

P698

Q33313648-CAFDC4B3-0663-4236-82D6-D26FD88AFC48

P921

Q33313648-B84F38C6-5652-4192-B815-8C7115071E1D

P932

Q33313648-4DB805F1-0943-4BE8-AED3-85B520B76FE5

P356

P1433

P1476

Genomic activation of the EGFR ...... ve epithelial ovarian cancers.

@en

P2093

Bart Neyns

http://www.w3.org/2001/XMLSchema#string

Claire Bourgain

http://www.w3.org/2001/XMLSchema#string

Erik Teugels

http://www.w3.org/2001/XMLSchema#string

Jacques De Grève

http://www.w3.org/2001/XMLSchema#string

Ji Xiangming

http://www.w3.org/2001/XMLSchema#string

Joanna Vermeij

http://www.w3.org/2001/XMLSchema#string

Peter in 't Veld

http://www.w3.org/2001/XMLSchema#string

Vanessa Ghislain

http://www.w3.org/2001/XMLSchema#string

P2860

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy.

Molecular determinants of the response of glioblastomas to EGFR kinase inhibitors.

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

Gefitinib-sensitizing EGFR mutations in lung cancer activate anti-apoptotic pathways

Erlotinib in previously treated non-small-cell lung cancer

Expression and function of EGF-related peptides and their receptors in gynecological cancer--from basic science to therapy.

Lung cancer: intragenic ERBB2 kinase mutations in tumours.

Epidermal growth factor receptor expression and gene amplification in colorectal carcinoma: an immunohistochemical and chromogenic in situ hybridization study.

EGF/ErbB receptor family in ovarian cancer.

Epidermal growth factor receptor gene and protein and gefitinib sensitivity in non-small-cell lung cancer.

P2888

P304

3

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1471-2407-8-3

http://www.w3.org/2001/XMLSchema#string

P407

P478

8

http://www.w3.org/2001/XMLSchema#string

P577

2008-01-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5668495

http://www.w3.org/2001/XMLSchema#string

P6179

1032941684

http://www.w3.org/2001/XMLSchema#string

P698

18182111

http://www.w3.org/2001/XMLSchema#string

P921

P932

2266762

http://www.w3.org/2001/XMLSchema#string